Form 4: Teladoc Health COO Michael Waters Reports Stock Transactions
SEC Form 4
Michael Waters, COO of Teladoc Health, reports the acquisition and disposal of company stock related to restricted stock units.
Summary
- On May 1, 2024, Michael Waters, the Chief Operating Officer of Teladoc Health, exercised 11,319 restricted stock units (RSUs) which converted to common stock on a one-for-one basis.
- On May 2, 2024, Waters sold 5,793 shares of common stock at a price of $12.688 per share.
- These shares were sold to cover tax withholding obligations related to the vesting of his restricted stock unit awards.
- Following these transactions, Waters directly owns 64,881 shares of Teladoc Health common stock and 56,599 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment about the company's performance.
Industry Context
This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, common among publicly traded companies. It provides transparency into the transactions of company insiders.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect routine executive compensation activities.
Key Dates
| Date | Description |
|---|---|
| 08/01/2022 | Reporting person was granted 135,833 restricted stock units. |
| 05/01/2024 | Restricted stock units converted to shares of TDOC common stock. |
| 05/02/2024 | Shares sold to cover the tax withholding obligation. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.